Advertisement


Serum Institute Of India
India  /  Published 18.01.21

Congress seeks vaccine free for poor

The Congress on Sunday asked Prime Minister Narendra Modi whether the country’s citizens, particularly the poor, would receive the Covid-19 vaccine free and wondered why pharmaceutical companies...
By Our Special Correspondent in New Delhi

India  /  Published 16.01.21

Adar Poonawalla takes Covishield jab

Adar Poonawalla, whose Serum Institute of India (SII) manufactured the first lot of COVID-19 vaccines, was among those who got vaccinated on Saturday, as India kicked off world's largest immunisat...
By Our Bureau, Agencies in New Delhi

Opinion  /  Published 06.01.21

Unclear shot: India vaccine roll out

Rolling out vaccines in the time of a raging pandemic in a nation as populous as India was bound to be accompanied by attendant challenges. But the lack of transparency and public anxiety regarding th...
By The Editorial Board

India  /  Published 06.01.21

Vaccine: export snub and truce

India has not banned the export of Covid-19 vaccines, the Union health secretary said on Tuesday, contradicting a claim by the head of the Serum Institute that the government would not allow exports f...
By G.S. Mudur in New Delhi

India  /  Published 05.01.21

Vaccine: SII-Bharat Biotech joint pledge

After their ugly public spat, Serum Institute of India and Bharat Biotech on Tuesday buried the hatchet and issued a joint statement saying they will work together to develop, manufacture and supply t...
By Our Bureau, Agencies in Hyderabad, Pune

Advertisement

India  /  Published 05.01.21

Corporate hostility among vaccine makers surfaces

Simmering undercurrents of business rivalry seem to have erupted into vocal corporate hostility between India’s two Covid-19 vaccine makers that medical experts say could leave the public confus...
By G.S. Mudur in New Delhi

India  /  Published 04.01.21

Covishield: cost to govt Rs 200-Rs 300

Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost USD 3-4 per shot (Rs 219-292) to the government and will be priced at double that rate in private market ones such s...
By Our Bureau, Agencies in New Delhi

India  /  Published 03.01.21

Emergency use nod for two vaccines in India

“It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of...
By Our Bureau, Agencies in New Delhi

India  /  Published 03.01.21

Covaxin jumps direct evidence

India’s drug regulatory expert panel on Saturday recommended conditional and restricted emergency use of a home-grown vaccine against the coronavirus disease without direct evidence for its prot...
By G.S. Mudur in New Delhi

India  /  Published 26.12.20

Vaccine: Oxford likely in India by Jan.

The Oxford vaccine may be the first one against Covid-19 to be rolled out in India, as the drug regulator in the country is looking forward to a UK nod to the vaccine, which according to sources is li...
By Our Bureau, Agencies in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.